MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Actigraphy wear compliance across CNS disorders

    J. Lavine, A. Pearlmutter, K. Momeni, R. Ellis (New York, USA)

    Objective: Examine actigraphy wear compliance in 5 neurological-disorders clinical trials using an ActiGraph GT9X Link with additional compliance features Background: Wrist worn biometric devices are…
  • 2023 International Congress

    Gene rearrangement as the cause of hereditary Hypomyelinating Leukodyistrophy disease type 5 (HLD5)

    A. Menéndez-Albarracín, P. Pastor-Muñoz, K. Beyer, M. Gea-Rispal, D. Vilas-Roldán, R. Alvarez-Ramo, L. Ispierto-González (Barcelona, Spain)

    Objective: To define the clinical, neurophysiological, neuroimaging and pathological findings from a patient carrying a FAM126A homozygous exon 3-7 deletion. Background: Hypomyelinating leukodystrophies constitute a…
  • 2023 International Congress

    Manifestations of aging and Parkinson’s Disease in low-frequency fluctuations of postural sway velocity

    M. Latka, K. Kozlowska, A. Latka, M. Glaubic-Latka, S. Budrewicz, M. Koszewicz, T. Sebzda, BJ. West (Wroclaw, Poland)

    Objective: To distinguish the effects of aging and Parkinson's disease on balance control. Background: Many balance control measures are derived from spontaneous fluctuations of the center…
  • 2023 International Congress

    Hemidystonia of cerebellar origin

    L. Costa, J. Pinto, C. Machado, I. Amorim (Viana do Castelo, Portugal)

    Objective: To report the case of a patient developing hemidystonia in the course of cerebellar hemorrhage. Background: About 1-4% of strokes may include movement disorders,…
  • 2023 International Congress

    Cholinergic subtyping in Parkinson disease: differential 2-year interval changes

    N. Bohnen, S. Roytman, T. Brown, K. Frey, P. Scott, R. Koeppe, R. Albin, P. Kanel (Ann Arbor, USA)

    Objective: To investigate 2-yr interval change in cholinergic transporters in biology-based cholinergic subgroups using serial VAChT [18F]FEOBV brain PET in Parkinson’s disease (PD). Background: Current…
  • 2023 International Congress

    Practice and outcome variation across Parkinson’s Foundation Centers of Excellence

    C. Marras, N. Dahodwala, J. Beck, A. Naito, Z. Meyer, A. Ramirez-Zamora, M. Neault, M. Rose Rafferty, T. Davis, H. Liu (Toronto, Canada)

    Objective: To identify center-level variations in Parkinson’s disease (PD) treatment practices and outcomes, and the relationship between treatment and outcomes to inform best practices Background:…
  • 2023 International Congress

    Acute-onset parkinsonism secondary to bilateral extrapontine myelinolysis of the basal ganglia: case report

    N. Sarhan (Zagazig, Egypt)

    Objective: Although rapid osmolar correction, mainly in the setting of hyponatremia is the main risk factor of osmotic demyelination syndrome, the pathogenesis of the syndrome…
  • 2023 International Congress

    Efficacy and safety of safinamide in PD patients over 70 years vs. under 70 years old;

    A. Ferreira, M. Rodrigues (Braga, Portugal)

    Objective: To search for any differences between efficacy and safety of safinamide in PD patients over 70 years vs. under 70 years old. Background: Safinamide…
  • 2023 International Congress

    Cognitive overlap between Parkinson disease (PD) and Alzheimer’s disease (AD) is associated with plasma biomarkers and their impact on regional cortical thickness (CT): An ONDRI Study

    M. Masellis, G. Coughlan, P. Zhukovsky, E. Sanchez, D. Munoz, R. Buckley, T. Steeves, P. Mclaughlin, D. Grimes, M. Jog, C. Marras, H. Zetterberg, H. Kvartsberg, M. Binns, SE. Black, AE. Lang (Toronto, Canada)

    Objective: To investigate cognitive performance across the Parkinson-Alzheimer’s spectrum and its association with plasma biomarkers and regional CT. Background: While PD and AD are neurodegenerative…
  • 2023 International Congress

    Verbal Fluency Changes After Unilateral STN Deep Brain Stimulation in Parkinson’s Disease: A Connectomics-Based Approach

    MJ. Kim, I. Zuccaroli, V. Del Bene, S. Brinkerhoff, R. Martin, J. Olson, M. Nelson, C. Gonzalez, V. Kamath, J. Bentley, B. Guthrie, R. Knight, H. Walker, K. Mills (Baltimore, USA)

    Objective: To investigate neural circuitry associated with verbal fluency changes after STN-DBS in Parkinson’s disease. Background: Despite its substantial motor benefits, subtle cognitive changes can…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley